How conversational AI mitigates physician burnout

Physician burnout is undoubtedly a serious issue in the medical profession—and it often stems from physicians’ EHR use, which, by some estimates, accounts for up to six hours of their daily work load. That's six hours is not dedicated to visiting with patients, a new article in Forbes suggests.

Nuance CEO Mark Benjamin spoke with Forbes to better explain the concept of “conversational AI,” which he believes may help cure physician burnout.

“Conversational AI uses intelligence to convert speech not just into text, but into text with meaning,” Benjamin said. “It understands the speaker’s intent in context, responds with relevant and helpful information and extracts key structured data that can drive actions and analytics.”

Within healthcare, and specifically physician burnout, conversational AI allows physicians to be free from feeling “hostage to regulatory and technology demands,” Benjamin noted. It helps improve physician productivity and well-being, job satisfaction and patient outcomes. 

Innovation within conversational AI is continually advancing. Benjamin said the next step in the evolution of conversational AI is virtual assistants. Innovators are working toward an “intelligent exam rooms” that listens to, captures and understand the conversations in the room, in real-time.

“The ultimate vision is to reinvent the entire doctor-patient experience in a way that allows clinical documentation to essentially write itself––and help cure physician burnout,” he said.

To read more, click the link below.

""

As a senior news writer for TriMed, Subrata covers cardiology, clinical innovation and healthcare business. She has a master’s degree in communication management and 12 years of experience in journalism and public relations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.